Elekta AB (publ) (OTCMKTS:EKTAY) Sees Large Decrease in Short Interest

Elekta AB (publ) (OTCMKTS:EKTAY) was the recipient of a large drop in short interest in February. As of February 28th, there was short interest totalling 100 shares, a drop of 66.7% from the February 13th total of 300 shares. Currently, 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 17,600 shares, the days-to-cover ratio is presently 0.0 days.

Wall Street Analysts Forecast Growth

Separately, Sanford C. Bernstein raised shares of Elekta AB (publ) from a “strong sell” rating to a “hold” rating in a report on Wednesday, January 29th.

Elekta AB (publ) Stock Performance

Shares of OTCMKTS:EKTAY traded up $0.25 during mid-day trading on Friday, reaching $5.60. The company had a trading volume of 16,942 shares, compared to its average volume of 9,312. The company has a current ratio of 1.05, a quick ratio of 0.81 and a debt-to-equity ratio of 0.60. The firm has a market cap of $2.15 billion, a price-to-earnings ratio of 22.39 and a beta of 1.25. The company’s 50-day moving average price is $5.75 and its 200-day moving average price is $6.01. Elekta AB has a one year low of $5.25 and a one year high of $8.24.

Elekta AB (publ) (OTCMKTS:EKTAY) last posted its quarterly earnings results on Friday, February 21st. The company reported $0.08 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.01). Elekta AB (publ) had a return on equity of 11.07% and a net margin of 5.65%. The company had revenue of $416.86 million during the quarter, compared to the consensus estimate of $435.89 million. As a group, equities research analysts anticipate that Elekta AB will post 0.36 EPS for the current fiscal year.

Elekta AB (publ) Cuts Dividend

The firm also recently disclosed a dividend, which will be paid on Thursday, March 27th. Investors of record on Friday, March 7th will be paid a $0.1072 dividend. The ex-dividend date is Friday, March 7th. Elekta AB (publ)’s dividend payout ratio is 40.00%.

About Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.